caption a7 caption a8 synergy Search Results


96
ATCC caption a7 caption a8 effect
Caption A7 Caption A8 Effect, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 caption a8 effect/product/ATCC
Average 96 stars, based on 1 article reviews
caption a7 caption a8 effect - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
New England Biolabs separate window caption a7 caption a8 brca2 c 67 3 a g splicing
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Separate Window Caption A7 Caption A8 Brca2 C 67 3 A G Splicing, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/separate window caption a7 caption a8 brca2 c 67 3 a g splicing/product/New England Biolabs
Average 96 stars, based on 1 article reviews
separate window caption a7 caption a8 brca2 c 67 3 a g splicing - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

97
GE Healthcare caption a7 caption a8 rett syndrome fusion organoids
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Caption A7 Caption A8 Rett Syndrome Fusion Organoids, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 caption a8 rett syndrome fusion organoids/product/GE Healthcare
Average 97 stars, based on 1 article reviews
caption a7 caption a8 rett syndrome fusion organoids - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Biacore biacore sensorgram
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Biacore Sensorgram, supplied by Biacore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biacore sensorgram/product/Biacore
Average 90 stars, based on 1 article reviews
biacore sensorgram - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments gmb-475
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Gmb 475, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gmb-475/product/CH Instruments
Average 90 stars, based on 1 article reviews
gmb-475 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Carl Zeiss zen blue 2
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Zen Blue 2, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zen blue 2/product/Carl Zeiss
Average 90 stars, based on 1 article reviews
zen blue 2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies bioanalyser high sensitive dna
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Bioanalyser High Sensitive Dna, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bioanalyser high sensitive dna/product/Agilent technologies
Average 90 stars, based on 1 article reviews
bioanalyser high sensitive dna - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Eppendorf AG caption a7 caption a8 egg holder plate silicone sealant
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Caption A7 Caption A8 Egg Holder Plate Silicone Sealant, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 caption a8 egg holder plate silicone sealant/product/Eppendorf AG
Average 96 stars, based on 1 article reviews
caption a7 caption a8 egg holder plate silicone sealant - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Illumina Inc illumina sequencing
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Illumina Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/illumina sequencing/product/Illumina Inc
Average 90 stars, based on 1 article reviews
illumina sequencing - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
ATCC caption a7 caption a8 ouabain inhibits reovirus infection atcc l929 cells
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Caption A7 Caption A8 Ouabain Inhibits Reovirus Infection Atcc L929 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 caption a8 ouabain inhibits reovirus infection atcc l929 cells/product/ATCC
Average 95 stars, based on 1 article reviews
caption a7 caption a8 ouabain inhibits reovirus infection atcc l929 cells - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Koehler Instrument bayesian network for dna match evidence
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Bayesian Network For Dna Match Evidence, supplied by Koehler Instrument, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bayesian network for dna match evidence/product/Koehler Instrument
Average 90 stars, based on 1 article reviews
bayesian network for dna match evidence - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Galectin Therapeutics galectin-1
A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of <t>BRCA2:c.67+3A>G</t> are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.
Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/galectin-1/product/Galectin Therapeutics
Average 90 stars, based on 1 article reviews
galectin-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of BRCA2:c.67+3A>G are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.

Journal: Molecular carcinogenesis

Article Title: Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2 : use of potential alternative start sites and implications for predicting variant pathogenicity

doi: 10.1002/mc.22116

Figure Lengend Snippet: A) Translation from all but one of these potential start codons (c.103) is predicted to result in an out-of-frame protein product. Two of the ATP-binding and hydrolysis domain motifs are shown (bases 91–129 and 187–204). Two further ATP-binding and hydrolysis motifs lie at bases 289–321 and 436–441. B) Alternative translation start sites following the aberrant splicing event as a result of BRCA2:c.67+3A>G are highlighted at position c.323 and c.367. The N-terminal transactivation domain that spans bases 67–315 is lost as a result of translation initiation at c.323 and c.367. In the event that the ATG at c.323 is recognized as the translation initiation signal, an out of frame protein would be synthesized terminating 12 amino acids after initiation. Initiation at c.367 would result in an in-frame protein product, lacking the N-terminal transactivation domain.

Article Snippet: Two downstream ATG sites in exon 4 at c.323 and c.367 were selected for functional analysis to determine their potential use as alternate translation initiation sites. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window caption a7 caption a8 BRCA2 :c.67+3A>G splicing products detected by RT-PCR M – 100bp DNA marker (New England Biolabs); Lane 1 variant carrier; Lanes 2–5, normal unaffected female controls; lane 6, no-template control.

Techniques: Binding Assay, Synthesized

Schematic representation of each construct is shown. The GFP sequence is in-frame with the most 3′ potential start site. Error bars are based on the standard error between repeat experiments. A) Relative GFP fluorescent level of predicted potential alternate start sites with and without the presence of the variant MLH1c.1A>G(p.Met1Val). The ATG at position c.103 is in-frame with the ATG at c.1, and produced higher GFP protein level than the two initiation sites not in-frame with position c.1 (c.89 and c.122, which are in-frame with each other). B) Effect of exon 2 loss from BRCA2 transcripts on the initiation of translation. An out-of-frame ATG codon at position c.323 in exon 4 is preferred to an in-frame alternative at c.370. Each experiment was conducted in triplicate, and then repeated twice.

Journal: Molecular carcinogenesis

Article Title: Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2 : use of potential alternative start sites and implications for predicting variant pathogenicity

doi: 10.1002/mc.22116

Figure Lengend Snippet: Schematic representation of each construct is shown. The GFP sequence is in-frame with the most 3′ potential start site. Error bars are based on the standard error between repeat experiments. A) Relative GFP fluorescent level of predicted potential alternate start sites with and without the presence of the variant MLH1c.1A>G(p.Met1Val). The ATG at position c.103 is in-frame with the ATG at c.1, and produced higher GFP protein level than the two initiation sites not in-frame with position c.1 (c.89 and c.122, which are in-frame with each other). B) Effect of exon 2 loss from BRCA2 transcripts on the initiation of translation. An out-of-frame ATG codon at position c.323 in exon 4 is preferred to an in-frame alternative at c.370. Each experiment was conducted in triplicate, and then repeated twice.

Article Snippet: Two downstream ATG sites in exon 4 at c.323 and c.367 were selected for functional analysis to determine their potential use as alternate translation initiation sites. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window caption a7 caption a8 BRCA2 :c.67+3A>G splicing products detected by RT-PCR M – 100bp DNA marker (New England Biolabs); Lane 1 variant carrier; Lanes 2–5, normal unaffected female controls; lane 6, no-template control.

Techniques: Construct, Sequencing, Variant Assay, Produced